Kali Inc KALY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $2.64
- Volume/Avg
- 38,000 / 96,434
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Kali Inc is a United States based company involved in cannabis extraction business. It focuses on development of pharmaceuticals to treat various illnesses, diseases and chronic pain as a symptom of various diagnoses. The company also concentrates on the development of health and wellness therapies.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 171
- Website
- https://www.kali-extracts.com
Valuation
|
Metric
|
KALY
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
KALY
Financial Strength
|
Metric
|
KALY
|
|---|---|
Quick Ratio | 5.17 |
Current Ratio | 5.33 |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
KALY
|
|---|---|
Return on Assets (Normalized) | 28.86% |
Return on Equity (Normalized) | 35.09% |
Return on Invested Capital (Normalized) | 34.63% |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Xcms | $84.8 Bil | |
MKKGY
| Merck KGaA ADR | Hlysvh | $66.6 Bil | |
HLN
| Haleon PLC ADR | Vmhy | $37.8 Bil | |
VTRS
| Viatris Inc | Pcfg | $11.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Jft | $11.5 Bil | |
CTLT
| Catalent Inc | Gkbjpv | $6.7 Bil | |
PRGO
| Perrigo Co PLC | Qqskw | $4.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Mscm | $3.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Pqgfn | $3.0 Bil | |
GTBIF
| Green Thumb Industries Inc | Ltxxf | $2.7 Bil |